Evidera has one of the largest, most well-respected teams in the industry. We are dedicated to advancing research and consultation in the life sciences industry, and our staff have influenced healthcare policy and decision making through work with NICE, IQWiG, FDA, EMA, CMS, HAS and many other organizations worldwide.
Industry pioneers with a long track record of success
20% of our scientists and consultants have 15+ years of experience, 80% have an advanced degree (MD, PhD, master’s, etc.)
Faculty appointments include: McGill University, Johns Hopkins University, University of North Carolina, and others
1,300+ research studies in progress
Authored 2,200+ peer-reviewed publications dating back to 1974, with more than 140 in 2018 alone
Experience across all major therapeutic areas, including many rare and orphan diseases
Frequently participate on society boards and committees, e.g., ISPOR, ISOQOL, AMCP, DIA, ISPE, HTAi, and MDM
In a recent independent survey of 9 biopharma companies, Evidera ranked highest in quality, ability to execute, analytical capabilities, relationship, content area expertise, and breadth of services.
